EU Panel Recommends Approval for 6 COPD, Asthma Drugs – Medscape

EU Panel Recommends Approval for 6 COPD, Asthma Drugs
Medscape
The 2 drugs receiving a positive CHMP opinion for treatment of adults with asthma and COPD are the combination of the inhaled corticosteroid budesonide and the long-acting ?2 agonist formoterol, under the brand names of DuoResp Spiromax and BiResp 
GSK lung drug Anoro recommended for European approvalWRAL Tech Wire
EU Agency backs respiratory drugs for approvalWTAQ
GSK share price: Pharma giant closes in on another COPD drug approval in iNVEZZ

all 64 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.